Nanovery
Curated by SignalDeveloper of nanobots for diagnosing cancer
Overview
Developer of nanobots for diagnosing cancer. The nanobots are administered into the bloodstream to identify specific cancer cell mutations and light upon finding the mutation. The company uses nanotechnology and AI to diagnose cancer.
Key facts
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Sign up to view
Open roles
1 roleBusiness Development Lead
Newcastle Upon Tyne, England, United Kingdom · On-site · Contract